Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/IIa, Single Site, Open-Label, Ascending Dose Study to Evaluate the Safety and Efficacy of OPF-310 [Encapsulated Porcine Islet Cells for Xenotransplantation] in Subjects With Type 1 Diabetes Mellitus

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06575426
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:19.228463+00:00
Published At
2026-03-02T00:00:00+00:00
Record Updated At
2026-03-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Diabetes Mellitus, Type 1", "Hypoglycemia", "Islet Cell Transplantation", "Type 1 Diabetes", "Type 1 Diabetes Mellitus", "T1D", "T1DM", "T1DM - Type 1 Diabetes Mellitus", "Type 1 Diabetes (T1D)", "Severe Hypoglycemia", "Xenotransplantation", "Hypoglycemic Episode", "Islet Transplantation in Diabetes Mellitus Type 1", "Glucose Metabolism Disorders (Including Diabetes Mellitus)", "Immune System Diseases", "Autoimmune Diseases", "Metabolic Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-02"
protocolSection.identificationModule.nctId
"NCT06575426"
protocolSection.identificationModule.officialTitle
"A Phase I/IIa, Single Site, Open-Label, Ascending Dose Study to Evaluate the Safety and Efficacy of OPF-310 [Encapsulated Porcine Islet Cells for Xenotransplantation] in Subjects With Type 1 Diabetes Mellitus"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Diabetes Mellitus, Type 1 (protocolSection.conditionsModule.conditions)
  • Hypoglycemia (protocolSection.conditionsModule.conditions)
  • Islet Cell Transplantation (protocolSection.conditionsModule.conditions)
  • Type 1 Diabetes (protocolSection.conditionsModule.conditions)
  • Type 1 Diabetes Mellitus (protocolSection.conditionsModule.conditions)
  • T1D (protocolSection.conditionsModule.conditions)
  • T1DM (protocolSection.conditionsModule.conditions)
  • T1DM - Type 1 Diabetes Mellitus (protocolSection.conditionsModule.conditions)
  • Type 1 Diabetes (T1D) (protocolSection.conditionsModule.conditions)
  • Severe Hypoglycemia (protocolSection.conditionsModule.conditions)
  • Xenotransplantation (protocolSection.conditionsModule.conditions)
  • Hypoglycemic Episode (protocolSection.conditionsModule.conditions)
  • Islet Transplantation in Diabetes Mellitus Type 1 (protocolSection.conditionsModule.conditions)
  • Glucose Metabolism Disorders (Including Diabetes Mellitus) (protocolSection.conditionsModule.conditions)
  • Immune System Diseases (protocolSection.conditionsModule.conditions)
  • Autoimmune Diseases (protocolSection.conditionsModule.conditions)
  • Metabolic Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.